Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T90553 | Target Info | |||
Target Name | Microtubule affinity regulating kinase 3 (MARK3) | ||||
Synonyms | cTAK1; Serine/threonine-protein kinase p78; Ser/Thr protein kinase PAR-1; Protein kinase STK10); Protein kinase STK10; Par-1a; MAP/microtubule affinity-regulating kinase 3; EMK2; EMK-2; ELKL motif kinase 2; Cdc25C-associated protein kinase 1; C-TAK1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | MARK3 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Protein Name | 14-3-3 protein zeta/delta (YWHAZ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3.zeta; HEL.S.3; HEL4; KCIP.1; YWHAD | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | M-phase inducer phosphatase 3 (MPIP3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Dual specificity phosphatase Cdc25C; Cdc25C phosphatase | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Biochemical Activity | [1] | |||
2 | Biochemical Activity | [3] | |||
3 | Biochemical Activity | [4] | |||
4 | Reconstituted Complex | [4] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Serine/threonine-protein kinase pim-1 (PIM1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PIM; Pim-1 proto-oncogene, serine/threonine kinase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Biochemical Activity | [3] | |||
3 | Yeast two hybrid | [3] | |||
Proteins 14-3-3 | [+] 1 Proteins 14-3-3 | + | |||
Interacting Target Name | AS1 14-3-3 protein eta (YWHAH) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | YWHA1; Protein AS1; 14-3-3 protein eta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [7] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation. J Cell Sci. 2006 Oct 1;119(Pt 19):4059-70. | ||||
REF 2 | Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy. Sci Signal. 2015 Apr 7;8(371):rs3. | ||||
REF 3 | The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem. 2004 Nov 12;279(46):48319-28. | ||||
REF 4 | C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 1998 Mar;9(3):197-208. | ||||
REF 5 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 6 | Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem. 2004 Mar 26;279(13):12804-11. | ||||
REF 7 | 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem J. 2010 Sep 15;430(3):393-404. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.